Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About IAI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Infection and Immunity
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About IAI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
MOLECULAR AND CELLULAR PATHOGENESIS

In Vivo Administration of Mycobacterial Cord Factor (Trehalose 6,6′-Dimycolate) Can Induce Lung and Liver Granulomas and Thymic Atrophy in Rabbits

Naoko Hamasaki, Ko-Ichi Isowa, Kohachi Kamada, Yoshitake Terano, Takayuki Matsumoto, Tetsuo Arakawa, Kazuo Kobayashi, Ikuya Yano
Naoko Hamasaki
Departments of Host Defense and
Gastroenterology, Osaka City University Graduate School of Medicine, Abeno-ku, Osaka 545-8585,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ko-Ichi Isowa
The Center of Japan Biological Chemistry, Kaizu-gunn, Gifu 503-0628, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kohachi Kamada
The Center of Japan Biological Chemistry, Kaizu-gunn, Gifu 503-0628, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoshitake Terano
Toneyama Institute for Tuberculosis Research, Toyonaka, Osaka 560-0045, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takayuki Matsumoto
Gastroenterology, Osaka City University Graduate School of Medicine, Abeno-ku, Osaka 545-8585,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tetsuo Arakawa
Gastroenterology, Osaka City University Graduate School of Medicine, Abeno-ku, Osaka 545-8585,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kazuo Kobayashi
Departments of Host Defense and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ikuya Yano
Departments of Host Defense and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/IAI.68.6.3704-3709.2000
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Trehalose 6,6′-dimycolate (TDM) is a cell surface molecule ofMycobacterium tuberculosis. TDM induced a loss of body weight and prominent granulomas in the liver and lungs by the intravenous injection of TDM into rabbits. TDM also induced atrophy of the thymus and spleen due to apoptosis. By contrast, sulfolipid (2,3,6,6′-tetraacyl trehalose 2′-sulfate) induced neither toxicity, nor granuloma formation, nor atrophy of the thymus and spleen. In rabbits the histopathological changes were more dramatic than in mice. The rabbit model may be more sensitive and may provide more information on the beneficial or pathological effects of TDM.

Tuberculosis has recently been reemerging, owing to human immunodeficiency virus infection, overcrowded populations, poverty, and the appearance of drug-resistant mycobacteria. Granuloma formation followed by caseous necrosis, liquefaction, and subsequent cavity formation are central processes in the pathology of human pulmonary tuberculosis, and these changes are induced by cell-mediated immune responses to mycobacterial infection (4, 16, 17). However, precise mechanisms and processes for the development of tuberculosis have not been fully clarified, particularly concerning the role of each cellular component or product of Mycobacterium tuberculosis at the molecular level. Among mycobacterial components, only trehalose 6,6′-dimycolate (TDM) can induce granulomatous lesions in experimental animals without protein antigen. To explore the role of delayed-type hypersensitivity to mycobacterial antigens, most immunologic studies of tuberculosis have been carried out using mice and guinea pigs (4).

Mice cannot develop cavitary lesions induced by tuberculosis. It has been reported that granulomatous changes in rabbit lungs are followed by caseous necrosis, liquefaction, and finally cavity formation by direct intrapulmonary injection of live or heat-killed bacilli or their components, including lipoprotein antigen and glycolipid (12, 14, 22). In the process, hydrolytic enzymes, including nucleases, proteinases, and cathepsin D from activated macrophages, participate in liquefaction and cavity formation (3–6). Using mouse models, we previously demonstrated granuloma- and cytokine-inducing activities of mycolyl glycolipids such as TDM (10, 15, 18, 20, 23). In mice, TDM and related mycolyl glycolipids (glucose mycolate or trehalose monomycolate) can induce foreign-body-type granulomas in the absence of protein antigens, although TDM cannot induce further pathological changes, even in hyperimmune mice. The rabbit is the only animal that readily produces tuberculous cavities (3, 22). Furthermore, tuberculosis in rabbits resembles human disease more closely than does tuberculosis in any other animal species (4, 13). The present study is the first report describing granuloma formation in rabbits that has been induced by the intravenous administration of protein-free TDM and the absence of granulomas with related glycolipids such as sulfolipid (SL; 2,3,6,6′-tetraacyltrehalose 2′-sulfate), another virulence factor of M. tuberculosis.

Rabbits.Specific-pathogen-free New Zealand White female rabbits, 8 weeks old (average body weight, 1.7 kg), were purchased from Japan KEARI Co. (Gifu, Japan).

Preparation of TDM and SL.TDM and SL were extracted from the total lipid of heat-killed M. tuberculosis AOYAMA-B. Each glycolipid was finally separated by preparative thin-layer chromatography of silica gel (Uniplate; 20 by 20 cm, 250 μm; Analtech, Inc., Newark, Del.). The purity of glycolipid was confirmed by fast atom bombardment mass spectrometry of the intact molecule with a JMSSX102A double-focusing mass spectrometer (JEOL, Tokyo, Japan) before and after hydrolysis of the cord factor. The result showed that the only hydrolysis products were α-, methoxy-, and keto-mycolic acids and trehalose (7).

In vivo administration of water-oil-water (w/o/w) emulsion of glycolipids.Purified TDM or SL was emulsified with 0.2% Tween 80 and 3.2% Freund's incomplete adjuvant (Difco, Detroit, Mich.) in 0.1 M phosphate-buffered saline to form w/o/w emulsion (18, 20). As controls, w/o/w emulsion micelles without glycolipids were used. Rabbits were injected intravenously with various doses of TDM or SL in the form of a w/o/w emulsion. Rabbits were sacrificed on day 2, 7, or 21 after the injection. For organ index determinations, lungs, liver, spleen, and thymus were removed. The organ index was calculated as the organ weight (in grams)/body weight (in grams) × 100. For histological examination, organs were fixed in 10% formalin and embedded in paraffin. Sections were stained with hematoxylin and eosin (HE).

Histopathological examination.To detect apoptotic changes, sections of the spleen and thymus were stained by TUNEL (terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end labeling) (TACSTM In Situ Apoptosis Detection Kit; Trevigen, Inc., Gaithersburg, Md.).

Statistical analysis.Data were analyzed by using Statview 5.0 (SAS Institute, Inc., Cary, N.C.) and expressed as the mean ± the standard deviation (SD). Data that appeared to be statistically significant were compared by an analysis of variance designed for comparing the means of multiple groups and then considered significant if the P values were <0.05.

Toxicity of TDM and SL.TDM induces a lethal toxicity in mice, when injected intravenously in w/o/w emulsion micelles (2). Intravenous injection of TDM into rabbits resulted in diarrhea and delay in the body weight increase in a dose-dependent fashion. Lethal toxicity was not observed in the rabbits administered a dose of 20 mg of TDM until 21 days after the challenge. The toxic effect on the rabbit body weight continued at least for 21 days after a single injection of TDM (Fig. 1). Administration of vehicle micelles served as a control, and SL induced neither lethal toxicity nor a delay in the increase in rabbit body weights.

Fig. 1.
  • Open in new tab
  • Download powerpoint
Fig. 1.

Time-dependent changes in body weight in rabbits challenged with either TDM or SL derived from M. tuberculosis AOYAMA-B. The data represent the mean ± the SD compiled from experiments with three to nine rabbits per condition. ∗, significant difference (P < 0.05) compared to the SL or control (CTRL) group.

Induction of granuloma formation.TDM induces foreign-body-type granulomas in mice by intravenous injection of w/o/w emulsion micelles (1). Intravenous injection of 3 to 20 mg of TDM per rabbit induced maximal granulomatous lesions in lungs 7 days after the injection. More than threefold increases in the lung weight and index were observed in a dose-dependent manner (Fig.2). The lung weight and index returned to baseline levels 21 days after injection (Fig.3). Grossly, lungs were enlarged and showed marked white granular surfaces, which in some parts fused with each other to form large and tightly infiltrated granulomas entirely in groups of rabbits given 10 to 20 mg of TDM. The weight of the liver and the liver index were not changed or rather decreased slightly for 7 to 21 days after injection of TDM, although small granulomas were clearly observed grossly 7 days after the injection. SL, however, did not induce significant granulomas in lungs and liver at 7 to 21 days after the challenge. Administration of w/o/w emulsion alone did not result in any significant changes in organ indices.

Fig. 2.
  • Open in new tab
  • Download powerpoint
Fig. 2.

Dose-related changes in organ indices of rabbits 7 days after the challenge with either TDM or SL. A more than threefold increase in the lung index was observed in rabbits given TDM. SL did not have any effect. Following the administration of TDM, thymic and splenic weights decreased to one-half of those of the controls. The data indicate the mean ± the SD compiled from experiments with three to nine rabbits per condition. Asterisks indicate a significant difference (∗, P < 0.05; ∗∗, P < 0.01 ) compared to the SL or control (CTRL) group.

Fig. 3.
  • Open in new tab
  • Download powerpoint
Fig. 3.

Time-related changes in organ indices of rabbits 2, 7, and 21 days after the injection with TDM or SL. The lung index and the atrophy of the thymus reached a peak at day 7 in rabbits given TDM. SL did not produce any changes. The data represent the mean ± the SD compiled from experiments with three to nine rabbits per condition. *, a significant difference ( P < 0.05) compared to the SL or control (CTRL) group.

Induction of thymic and splenic atrophy.TDM induces remarkable atrophy of the thymus in mice due to apoptosis when injected intravenously in w/o/w emulsion micelles (18). Intravenous injection of TDM into rabbits induced peak atrophy of both the thymus and the spleen by day 7. The weights of the thymus and spleen were reduced to one-half or less of those of the controls (Fig. 2). Atrophy of the thymus and spleen was dose responsive, and organ weights reached a minimum on day 7 after the injection and returned to the control level on day 21, paralleled by the lung granuloma formation and resolution (Fig. 3). Administration of emulsion without glycolipids or with SL showed neither atrophy nor a decrease in the organ weight of the rabbit thymus or spleen.

Histopathological changes.Histological changes were observed distinctively in the lungs, liver, thymus, and spleen 7 days after injection of TDM. In rabbits given 20 mg of TDM, the lungs showed solidification due to the loss of normal alveolar structure. Numerous lightly stained mature epithelioid cells and lymphocytes with fewer neutrophils infiltrated into the alveolar space to form well-organized granulomas, although no distinctive caseation and necrosis were observed (Fig. 4). Multinucleated giant cells could be observed occasionally. Scattered areas of pneumonia and perivasculitis were also seen in the lungs. SL did not induce granulomas in the lungs and liver, although focal pneumonia, mild perivasculitis, and slight macrophage infiltration were found. In the livers of rabbits injected with 10 to 20 mg of TDM, significant granuloma formation was observed (Fig. 4). These granulomas were solitary but highly organized and islet-like. In the livers of rabbits injected with 20 mg of TDM, foreign-body-type multinucleated giant cells and lymphocyte infiltration were observed mostly in the marginal region of granulomatous lesions. It was particularly noted that in the central region of liver granulomas, significant focal necrosis of hepatocytes was observed, suggesting that a large amount of TDM administration might induce liver damage due to its potent toxicity (11). In thymus tissues of rabbits injected with 10 to 20 mg of TDM, apoptotic nuclei or nuclear condensation was observed by HE and TUNEL staining (Fig. 5). Electron microscopically marked nuclear condensation and karyorrhectic changes in thymic cortical lymphocytes were observed (data not shown). In the spleens of rabbits given 10 to 20 mg of TDM, both granulomatous and apoptotic changes were observed in the white pulp. In addition, follicular hyperplasia and splenitis were observed in rabbits injected with TDM. Follicle formation, indicating the development of humoral immunity, was also observed in the spleens of TDM-injected rabbits. SL did not induce any significant changes such as apoptosis in the thymus and spleen (Table 1). Granulomatous changes in lungs and livers continued up to 21 days after the challenge, but the size and number of lung granulomas decreased significantly. By contrast, rabbits given SL did not show significant granulomatous changes in lungs and livers on days 7 to 21. The apoptotic changes in the thymus and spleen elicited by administration of TDM disappeared by day 21; however, granulomas of the spleen and splenitis induced by TDM or SL (10 mg) continued for a longer period of time.

Fig. 4.
  • Open in new tab
  • Download powerpoint
Fig. 4.

Histopathology of lung and liver granulomas in a rabbit challenged with TDM or SL (HE stain). The rabbit was sacrificed 7 days after the challenge with 20 mg of TDM. In the lung, alveolar spaces were fully replaced with granulomatous lesions (>90% of alveolar space area), and the normal alveolar structure disappeared. The development of lung granulomas was dose responsive. Typical granulomas induced by TDM were characteristic in that they consisted of large macrophages with lightly stained round nuclei (epithelioid cells) infiltrated into the central region with lymphocytes with densely stained nuclei in the marginal region. In the livers of rabbits given 20 mg of TDM, solitary granulomas with occasional multinucleated giant cells were seen. The number of solitary granulomas was dependent on the dose of TDM injected. In the central region, macrophages, epithelioid cells, and hepatocytes were stained lightly, and their nuclei could hardly be seen, a result probably due to necrosis or apoptosis. Lymphocytes infiltrated into the marginal region of granulomas were observed.

Fig. 5.
  • Open in new tab
  • Download powerpoint
Fig. 5.

Apoptosis of thymocytes and splenocytes in rabbits challenged with SL or TDM (TUNEL stain). Rabbits were sacrificed 7 days after the challenge. Cortical lymphocytes were decreased, and apoptosis was noted in the thymus of a rabbit given TDM. Foci of apoptotic lymphocytes could be seen in the white pulp of the spleen from a rabbit challenged with TDM.

View this table:
  • View inline
  • View popup
Table 1.

Histopathological findings in New Zealand White rabbits given a single intravenous administration of glycolipids fromM. tuberculosis AOYAMA-Ba

TDM is a toxic substance in mice, although it possesses potent adjuvant activity by stimulating cell-mediated immunity with coadministration of protein antigen (19). This adjuvant activity and granulomatogenic activity can be further potentiated by costimulation with other cellular components, such as cell wall skeleton derived from tubercle bacilli (19). Because mycobacterial TDM showed a potent toxicity and marked granuloma-inducing activity in rabbits, these highly organized granulomatous lesions may play an important role in bactericidal activity. On the other hand, since mycobacterial TDM has been reported to be toxic in mice due to the inhibition of liver mitochondrial electron transport systems (11), such a toxic effect may play a role in the liver damage in rabbits. At present, it is difficult to conclude whether such toxic effects induce tissue necrosis directly or indirectly, and we need more precise and immunological observation of histological changes of granulomatous tissues after TDM administration.

Thymic atrophy induced by TDM was closely related to granuloma formation in mice (18). Because thymectomized mice fail to develop Mycobacterium bovis BCG cell wall-induced lung granulomas but restore their capacity to respond after the transfer of thymic or splenic cells, thymocytes appeared to be necessary for T-cell-mediated granulomatous responses in mice (9). TDM-induced granulomas in rabbits were also paralleled by marked atrophy of the thymus and spleen, suggesting that thymus or T lymphocytes may play an important role in the development of lung granulomas. SL did not induce granuloma formation or cause thymic and splenic atrophy. Although TDM and SL possess a common structure in having a trehalose moiety, the different biological effects of these two compounds observed here must be derived from the differences in the fatty acid moieties (8). Such cell surface molecules make contact with host cells and stimulate them at the early stage of the infection. Mycobacterial TDM may contact a larger part of the host cell surface than SL does, thus causing extensive stimulation of host cells.

The exact physiological role of apoptosis induced by TDM must be clarified. The thymic and splenic atrophy produced by TDM could result in the negative selection, involving activation-induced T-cell death, before the specific cellular immunity against M. tuberculosis antigen develops. We have reported previously that abundant NK cells and extrathymic T lymphocytes are found in lung granulomas induced by TDM challenge in mice (20). The biological effect of TDM is a double-edged sword in tuberculosis. TDM shows granuloma-inducing activity, a benefit associated with gamma interferon production and intracellular killing (21). In contrast, TDM shows detrimental functions such as lethal toxicity, loss of body weight, liver damage, and temporal immunosuppression in mice and rabbits. Probably, the balance of these two potentials determines whether the disease progresses or regresses.

The challenge for the future will be to understand and clarify the precise role of TDM in the pathophysiology of mycobacterial infections in rabbits. Such an understanding may open new avenues for better interventions against tuberculosis in rabbits as well as humans.

ACKNOWLEDGMENTS

We thank Tetsuo Kuroki for helpful suggestions.

This work was supported by grants of Research on Emerging and Re-emerging Infectious Diseases (Health Sciences Research Grants, Ministry of Health and Welfare) and The United States-Japan Cooperative Medical Science Program against Tuberculosis and Leprosy.

Notes

Editor: S. H. E. Kaufmann

FOOTNOTES

    • Received 11 October 1999.
    • Returned for modification 25 November 1999.
    • Accepted 15 February 2000.
  • Copyright © 2000 American Society for Microbiology

REFERENCES

  1. 1.↵
    1. Bekierkunst A.,
    2. Levij I. S.,
    3. Yarkoni E.,
    4. Vilkas E.,
    5. Adam A.,
    6. Lederer E.
    Granuloma formation induced in mice by chemically defined mycobacterial fractions.J. Bacteriol.100196995102
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Bloch H.
    Studies on the virulence of tubercle bacilli. Isolation and biological properties of a constituent of virulent organisms.J. Exp. Med.911950197219
    OpenUrlAbstract
  3. 3.↵
    1. Converse P. J.,
    2. Dannenberg A. M. Jr.,
    3. Estep J. E.,
    4. Sugisaki K.,
    5. Abe Y.,
    6. Schofield B. H.,
    7. Pitt M. L. M.
    Cavitary tuberculosis produced in rabbits by aerosolized virulent tubercle bacilli.Infect. Immun.64199647764787
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Dannenberg A. M. Jr.
    Delayed-type hypersensitivity and cell-mediated immunity in the pathogenesis of tuberculosis.Immunol. Today121991228233
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.
    1. Dannenberg A. M. Jr.
    Immunopathogenesis of pulmonary tuberculosis.Hosp. Pract.1519935158
    OpenUrl
  6. 6.
    1. Dannenberg A. M. Jr.
    Rabbit model of tuberculosis Tuberculosis: pathogenesis, protection, and control. Bloom B. R. 1994 149 156 ASM Press Washington, D.C.
  7. 7.↵
    1. Fujiwara N.,
    2. Pan J.,
    3. Enomoto K.,
    4. Terano Y.,
    5. Honda T.,
    6. Yano I.
    Production and partial characterization of anti-cord factor (trehalose-6,6′-dimycolate) IgG antibody in rabbits recognizing mycolic acid subclass of Mycobacterium tuberculosis or Mycobacterium avium.FEMS Immunol. Med. Microbiol.241999141149
    OpenUrlPubMedWeb of Science
  8. 8.↵
    1. Goren M. B.,
    2. Brokl O.,
    3. Das B. C.
    Sulfatides of Mycobacterium tuberculosis: the structure of the principal sulfatide (SL-1).Biochemistry15197627282735
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Kakimura M.,
    2. Onoe K.,
    3. Okada M.,
    4. Kimura T.,
    5. Kato K.,
    6. Okuyama H.,
    7. Morikawa K.,
    8. Yamamoto K.
    Failure of C3H mice to develop lung granuloma after intravenous injection of BCG cell wall vaccine.Immunology43198119
    OpenUrlPubMed
  10. 10.↵
    1. Kaneda K.,
    2. Sumi Y.,
    3. Kurano F.,
    4. Kato Y.,
    5. Yano I.
    Granuloma formation and hemopoiesis induced by C36–48-mycolic acid-containing glycolipids from Nocardia rubra.Infect. Immun.541986869875
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    1. Kato M.
    Studies of a biochemical lesion in experimental tuberculosis in mice. VIII. Structural and functional damage in mouse liver mitochondria under the toxic action of cord factor.Am. Rev. Respir. Dis.981968260269
    OpenUrlPubMed
  12. 12.↵
    1. Lurie M. B.
    The correlation between the histological changes and the fate of living tubercle bacilli in the organs of tuberculous rabbits.J. Exp. Med.5519323154
    OpenUrlAbstract
  13. 13.↵
    1. Lurie M. B.
    Resistance to tuberculosis: experimental studies in native and acquired defensive mechanisms. 1964 Harvard University Press Cambridge, Mass
  14. 14.↵
    1. Maeda H.,
    2. Yamamura Y.,
    3. Ogawa Y.
    Mycobacterial antigens relating to experimental pulmonary cavity formation.Am. Rev. Respir. Dis.1151977617623
    OpenUrlPubMed
  15. 15.↵
    1. Matsunaga I.,
    2. Oka S.,
    3. Fujiwara N.,
    4. Yano I.
    Relationship between induction of macrophage chemotactic factors and formation of granulomas caused by mycolyl glycolipids from Rhodococcus ruber (Nocardia rubra).J. Biochem.1201996663670
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Myrvik Q. N.
    Immunopathology of pulmonary tuberculosis.Adv. Exp. Med. Biol.1551982649657
    OpenUrlPubMed
  17. 17.↵
    1. Myrvik Q. N.,
    2. Leake E. S.,
    3. Tenner-Racz K.
    Interaction of mycobacteria with normal and immunologically activated alveolar macrophages.Adv. Exp. Med. Biol.16219838398
    OpenUrlPubMed
  18. 18.↵
    1. Ozeki Y.,
    2. Kaneda K.,
    3. Fujiwara N.,
    4. Morimoto M.,
    5. Oka S.,
    6. Yano I.
    In vivo induction of apoptosis in the thymus by administration of mycobacterial cord factor (trehalose 6,6′-dimycolate).Infect. Immun.65199717931799
    OpenUrlAbstract/FREE Full Text
  19. 19.↵
    1. Ribi E.,
    2. Granger D. L.,
    3. Milner K. C.,
    4. Yamamoto K.,
    5. Strain S. M.,
    6. Parker R.,
    7. Smith R. W.,
    8. Brehmer W.,
    9. Azuma I.
    Induction of resistance to tuberculosis in mice with defined components of mycobacteria and with some unrelated materials.Immunology461982297305
    OpenUrlPubMedWeb of Science
  20. 20.↵
    1. Tabata T.,
    2. Kaneda K.,
    3. Watanabe H.,
    4. Abo T.,
    5. Yano I.
    Kinetics of organ-associated natural killer cells and intermediate CD3 cells during pulmonary and hepatic granulomatous inflammation induced by mycobacterial cord factor.Microbiol. Immunol.401996651658
    OpenUrlPubMed
  21. 21.↵
    1. Watanabe K.,
    2. Hasunuma R.,
    3. Horikoshi T.,
    4. Yamana H.,
    5. Maruyama H.,
    6. Fujiwara N.,
    7. Kumazawa Y.,
    8. Yano I.
    Induction of hypersensitivity to endotoxin lethality in mice by treatment with trehalose 6,6′-dimycolate but not with 2,3,6,6′-tetraacyl trehalose 2′-sulfate.J. Endotoxin Res.519992330
    OpenUrl
  22. 22.↵
    1. Yamamura Y.,
    2. Maeda H.,
    3. Ogawa Y.
    Experimental pulmonary cavity formation by mycobacterial components and synthetic adjuvants.Microbiol. Immunol.30198611751187
    OpenUrlPubMed
  23. 23.↵
    1. Yano I.,
    2. Tomiyasu I.,
    3. Kitabatake S.,
    4. Kaneda K.
    Granuloma forming activity of mycolic acid-containing glycolipids in Nocardia and related taxa.Acta Leprol.21984341349
    OpenUrlPubMed
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
In Vivo Administration of Mycobacterial Cord Factor (Trehalose 6,6′-Dimycolate) Can Induce Lung and Liver Granulomas and Thymic Atrophy in Rabbits
Naoko Hamasaki, Ko-Ichi Isowa, Kohachi Kamada, Yoshitake Terano, Takayuki Matsumoto, Tetsuo Arakawa, Kazuo Kobayashi, Ikuya Yano
Infection and Immunity Jun 2000, 68 (6) 3704-3709; DOI: 10.1128/IAI.68.6.3704-3709.2000

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Infection and Immunity article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
In Vivo Administration of Mycobacterial Cord Factor (Trehalose 6,6′-Dimycolate) Can Induce Lung and Liver Granulomas and Thymic Atrophy in Rabbits
(Your Name) has forwarded a page to you from Infection and Immunity
(Your Name) thought you would be interested in this article in Infection and Immunity.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
In Vivo Administration of Mycobacterial Cord Factor (Trehalose 6,6′-Dimycolate) Can Induce Lung and Liver Granulomas and Thymic Atrophy in Rabbits
Naoko Hamasaki, Ko-Ichi Isowa, Kohachi Kamada, Yoshitake Terano, Takayuki Matsumoto, Tetsuo Arakawa, Kazuo Kobayashi, Ikuya Yano
Infection and Immunity Jun 2000, 68 (6) 3704-3709; DOI: 10.1128/IAI.68.6.3704-3709.2000
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • ACKNOWLEDGMENTS
    • Notes
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Cord Factors
granuloma
liver
lung
Mycolic Acids
Thymus Gland
trehalose

Related Articles

Cited By...

About

  • About IAI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #IAIjournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0019-9567; Online ISSN: 1098-5522